Home / Healthcare / Biomarkers

Biomarkers

Published: Jul 2013 | No Of Pages: 700 | Published By: RI Technologies

This report on Biomarkers focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc. The study provides global market analysis for biomarkers by the above disease areas and also by prominent biomarker identification technologies including imaging, genomics, proteomics, metabolomics, gene expression and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology. Compilation of Worldwide Patents and Research related to Biomarkers is also provided. The report offers market values for global geographic regions including North America, Europe, Asia-Pacific and Rest of World.

1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS
2.1 Introduction
2.2 Segmentation of Biomarkers
Exhibit 1. Segmentation of Global Biomarkers Market by Therapeutic Area and Identification Technology
Identification Technologies
Imaging
Genomics
Proteomics
Metabolomics
Gene Expression
Therapeutic Areas
Oncology
Cardiology
Neurology
Infectious Diseases
Exhibit 2. Segmentation by Therapeutic Area for Oncology, Cardiology, Neurology, and Infectious Diseases
2.3 Global Biomarkers Market
Exhibit 3. Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Billion (Graphical Representation Included)
Exhibit 4. List of Global Major Biomarkers Companies

3. MARKET DYNAMICS
3.1 Global Market Overview
3.2 Global Biomarkers Market
Exhibit 5. Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 6. Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.3 North American Biomarkers Market
Exhibit 7. Biomarkers – North American Market Estimations & Predictions (2005 -2020) in US$ Million for United States and Canada (Graphical Representation Included)
Exhibit 8. Biomarkers – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.3 (I) United States Biomarkers Market
3.3 (II) Canadian Biomarkers Market
Exhibit 9. List of North American Biomarkers Companies
3.4 European Biomarkers Market
Exhibit 10. Biomarkers – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 11. Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.4 (I) German Biomarkers Market
3.4 (II) United Kingdom Biomarkers Market
3.4 (III) Italian Biomarkers Market
3.4 (IV) French Biomarkers Market
3.4 (V) Spanish Biomarkers Market
3.4 (VI) Swiss Biomarkers Market
3.4 (VII) Belgian Biomarkers Market
3.4 (VIII) Swedish Biomarkers Market
3.4 (IX) Russian Biomarkers Market
Exhibit 12. List of European Biomarkers Companies
3.5 Asia-Pacific Biomarkers Market
Exhibit 13. Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 14. Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.5 (I) Japanese Biomarkers Market
3.5 (II) Chinese Biomarkers Market
3.5 (III) Indian Biomarkers Market
3.5 (IV) Australian Biomarkers Market
3.5 (V) South Korean Biomarkers Market
Exhibit 15. List of Asia-Pacific Biomarkers Companies
3.6 Rest of World Biomarkers Market
Exhibit 16. Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 17. Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.6 (I) Israeli Biomarkers Market
3.6 (II) South African Biomarkers Market
3.6 (III) Brazilian Biomarkers Market
Exhibit 18. List of Rest of World Biomarkers Companies
3.7 Market Trends
What are Pharma Companies Looking For in Biomarkers?
Biomarkers – An Emerging Trend in Pharma Industry
Innovative Biomarker Discovery Methods Aid in Drug Development Stages
Biomarkers Becoming Important in Developing Better Drugs
Pharma Companies Investing Huge Amounts in Biomarkers Discovery
3.8 Company Profiles – Major Players in Biomarker Market
Abbott Diagnostics (USA)
Affymetrix, Inc. (USA)
Agendia BV ((The Netherlands))
Agilent Technologies, Inc. (USA)
AltheaDx, Inc. (USA)
More….
3.9 Major Activities in Biomarker Industry
Exonhit and Pfizer Enters into Research Agreement for AD Biomarkers Identification
IVD Acquisition Corporation Takes Over Immucor
TcLand Expression Strategic Partnership for Development of Novel RA Biomarkers
Stemina Biomarker and Pioneer Hi-Bred Sign Research Agreement
Astellas Pharma Completes Acquisition of OSI Pharmaceuticals
OriGene and ISB alliance for SRM/MRM database
Duke Associates with LabCorp to Develop a Joint Venture Company, the Biomarker Factory
Thermo Fisher Enters into a Collaboration Agreement with LCP for Improved Biomarker Discovery and Assay Development Process…
Axela Associates with Salomao & Zoppi and CRIA Opportunities
SQI Diagnostics Enters into a Development Deal with Silliker for Marketing of Botulism Toxin Panel
PROOF Centre Enters into Partnership Agreement with Luminex
Celerion Completes Acquisition of MDS Pharma Services' Early Stage Clinical Development Operations
Philips Signs a MoU with Definiens for Co-Developing and Marketing Solutions for Digital Pathology
Ricerca Biosciences LLC Purchases MDS Pharma Services
PAREXEL International and Proteome Sciences Forms an Alliance for Biomarker Development
Biocartis Acquires Automated DNA/RNA Molecular Diagnostic Testing Platform of Philips
More….
3.10 Major Product Innovations/Launches in Biomarker Industry
AB SCIEX Expands Eksigent Chip Column Family for Nano and Micro LC Proteomics Analysis
WaferGen Biosystems Supplies SmartChip Real-Time PCR System to Kyoto University for Enhancing the Research on Regenerative Tissue
C-Path Becomes First Ever Biomarker Panel to be Approved by Japanese Regulators
Tethys Inc., Receives US Patent for the Outstanding PreDx™ Diabetes Risk Score Test
Millipore Launches Test Kits for Human Kidney Damage
TGen Piloted Group Led Studies Identify Genetic Links to Kidney Disease
WaferGen Biosystems Inc., Markets Two of Gene Expression Profiling Panels Designed for SmartChip Real-Time PCR System
Cancer Prevention and Research Institute of Texas Awards Funds to Rules-Based Medicine
Quintiles Launches Wide-Ranging Suite of PI3K Biomarker Assays
BioMarker Strategies Obtains Funds of US$1 Million from NCI
StemTroniX and Power3 Submit Patent Application for Stem Cell Protein Biomarkers
Pronota Achieves Base of Next Generation Sequencing Application for Identification and Quantification of Proteins
bioMérieux and GlaxoSmithKline Enter into Alliance for the Development of Molecular Theranostic Test
More…..
3.11 Therapeutic Area Analysis
Exhibit 19. Biomarkers by Therapeutic Area – Global Market Estimations and Predictions (2005-2020) in US$ Million for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included)
Exhibit 20. Biomarkers – Global Market Shares (2010, 2015 & 2020) for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included)
3.11.1 ONCOLOGY
3.11.1.1 Global Oncology Biomarkers Market
Exhibit 21. Biomarkers in Oncology – Global Market Estimations and Predictions (2005-2020) in US$ Million for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included)
Exhibit 22. Biomarkers in Oncology – Global Market Shares (2010, 2015 & 2020) for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included)
Exhibit 23. Biomarkers in Oncology – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 24. Biomarkers in Oncology – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.1.2 North American Oncology Biomarkers Market
Exhibit 25. Biomarkers in Oncology – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 26. Biomarkers in Oncology – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.1.2 (I) United States Oncology Biomarkers Market
3.11.1.2 (II) Canadian Oncology Biomarkers Market
Exhibit 27. List of North American Oncology Biomarkers Companies
3.11.1.3 European Oncology Biomarkers Market
Exhibit 28. Biomarkers in Oncology – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 29. Biomarkers in Oncology – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.11.1.3 (I) German Oncology Biomarkers Market
3.11.1.3 (II) United Kingdom Oncology Biomarkers Market
3.11.1.3 (III) Italian Oncology Biomarkers Market
3.11.1.3 (IV) French Oncology Biomarkers Market
3.11.1.3 (V) Spanish Oncology Biomarkers Market
3.11.1.3 (VI) Swiss Oncology Biomarkers Market
3.11.1.3 (VII) Belgian Oncology Biomarkers Market
3.11.1.3 (VIII) Swedish Oncology Biomarkers Market
3.11.1.3 (IX) Russian Oncology Biomarkers Market
Exhibit 30. List of European Oncology Biomarkers Companies
3.11.1.4 Asia-Pacific Oncology Biomarkers Market
Exhibit 31. Biomarkers in Oncology – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 32. Biomarkers in Oncology– Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.1.4 (I) Japanese Oncology Biomarkers Market
3.11.1.4 (II) Chinese Oncology Biomarkers Market
3.11.1.4 (III) Indian Oncology Biomarkers Market
3.11.1.4 (IV) Australian Oncology Biomarkers Market
3.11.1.4 (V) South Korean Oncology Biomarkers Market
Exhibit 33. List of Asia-Pacific Oncology Biomarkers Companies
3.11.1.5 Rest of World Oncology Biomarkers Market
Exhibit 34. Biomarkers in Oncology – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 35. Biomarkers in Oncology – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.1.5 (I) Israeli Oncology Biomarkers Market
3.11.1.5 (II) South African Oncology Biomarkers Market
3.11.1.5 (III) Brazilian Oncology Biomarkers Market
Exhibit 36. List of Rest of World Oncology Biomarkers Companies
3.11.1.A PROSTATE CANCER
3.11.1.A .1 Global Prostate Cancer Biomarkers Market
Exhibit 37. Prostate Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 38. Prostate Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.1.A .2 North American Prostate Cancer Biomarkers Market
Exhibit 39. Prostate Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 40. Prostate Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.1.A .2 (I) United States Prostate Cancer Biomarkers Market
3.11.1.A .2 (II) Canadian Prostate Cancer Biomarkers Market
Exhibit 41. List of North American Prostate Cancer Biomarkers Companies
3.11.1.A .3 European Prostate Cancer Biomarkers Market
Exhibit 42. Prostate Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 43. Prostate Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.1.A .3 (I) German Prostate Cancer Biomarkers Market
3.11.1.A .3 (II) United Kingdom Prostate Cancer Biomarkers Market
3.11.1.A .3 (III) Italian Prostate Cancer Biomarkers Market
3.11.1.A .3 (IV) French Prostate Cancer Biomarkers Market
3.11.1.A .3 (V) Spanish Prostate Cancer Biomarkers Market
3.11.1.A .3 (VI) Swiss Prostate Cancer Biomarkers Market
3.11.1.A .3 (VII) Belgian Prostate Cancer Biomarkers Market
3.11.1.A .3 (VIII) Swedish Prostate Cancer Biomarkers Market
3.11.1.A .3 (IX) Russian Prostate Cancer Biomarkers Market
Exhibit 44. List of European Prostate Cancer Biomarkers Companies
3.11.1.A .4 Asia-Pacific Prostate Cancer Biomarkers Market
Exhibit 45. Prostate Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 46. Prostate Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.1.A .4 (I) Japanese Prostate Cancer Biomarkers Market
3.11.1.A .4 (II) Chinese Prostate Cancer Biomarkers Market
3.11.1.A .4 (III) Indian Prostate Cancer Biomarkers Market
3.11.1.A .4 (IV) Australian Prostate Cancer Biomarkers Market
3.11.1.A .4 (V) South Korean Prostate Cancer Biomarkers Market
Exhibit 47. List of Asia-Pacific Prostate Cancer Biomarkers Companies
3.11.1.A .5 Rest of World Prostate Cancer Biomarkers Market
Exhibit 48. Prostate Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 49. Prostate Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.1.A .5 (I) Israeli Prostate Cancer Biomarkers Market
3.11.1.A .5 (II) South African Prostate Cancer Biomarkers Market
3.11.1.A .5 (III) Brazilian Prostate Cancer Biomarkers Market
3.11.1. B OVARIAN CANCER
3.11.1.B .1 Global Ovarian Cancer Biomarkers Market
Exhibit 50. Ovarian Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 51. Ovarian Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.1. B .2 North American Ovarian Cancer Biomarkers Market
Exhibit 52. Ovarian Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 53. Ovarian Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada
(Graphical Representation Included)
3.11.1. B .2 (I) United States Ovarian Cancer Biomarkers Market
3.11.1. B .2 (II) Canadian Ovarian Cancer Biomarkers Market
Exhibit 54. List of North American Ovarian Cancer Biomarkers Companies
3.11.1. B .3 European Ovarian Cancer Biomarkers Market
Exhibit 55. Ovarian Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 56. Ovarian Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.1. B .3 (I) German Ovarian Cancer Biomarkers Market
3.11.1. B .3 (II) United Kingdom Ovarian Cancer Biomarkers Market
3.11.1. B .3 (III) Italian Ovarian Cancer Biomarkers Market
3.11.1. B .3 (IV) French Ovarian Cancer Biomarkers Market
3.11.1. B .3 (V) Spanish Ovarian Cancer Biomarkers Market
3.11.1. B .3 (VI) Swiss Ovarian Cancer Biomarkers Market
3.11.1. B .3 (VII) Belgian Ovarian Cancer Biomarkers Market
3.11.1. B .3 (VIII) Swedish Ovarian Cancer Biomarkers Market
3.11.1. B .3 (IX) Russian Ovarian Cancer Biomarkers Market
Exhibit 57. List of European Ovarian Cancer Biomarkers Companies
3.11.1. B .4 Asia-Pacific Ovarian Cancer Biomarkers Market
Exhibit 58. Ovarian Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 59. Ovarian Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.1. B .4 (I) Japanese Ovarian Cancer Biomarkers Market
3.11.1. B .4 (II) Chinese Ovarian Cancer Biomarkers Market
3.11.1. B .4 (III) Indian Ovarian Cancer Biomarkers Market
3.11.1. B .4 (IV) Australian Ovarian Cancer Biomarkers Market
3.11.1. B .4 (V) South Korean Ovarian Cancer Biomarkers Market
Exhibit 60. List of Asia-Pacific Ovarian Cancer Biomarkers Companies
3.11.1. B .5 Rest of World Ovarian Cancer Biomarkers Market
Exhibit 61. Ovarian Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 62. Ovarian Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil
and Other Countries (Graphical Representation Included)
3.11.1. B .5 (I) Israeli Ovarian Cancer Biomarkers Market
3.11.1. B .5 (II) South African Ovarian Cancer Biomarkers Market
3.11.1. B .5 (III) Brazilian Ovarian Cancer Biomarkers Market
Exhibit 63. List of Rest of World Ovarian Cancer Biomarkers Companies
3.11.1. C BREAST CANCER
3.11.1. C.1 Global Breast Cancer Biomarkers Market
Exhibit 64. Breast Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 65. Breast Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.1. C.2 North American Breast Cancer Biomarkers Market
Exhibit 66. Breast Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 67. Breast Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.1. C.2 (I) United States Breast Cancer Biomarkers Market
3.11.1. C.2 (II) Canadian Breast Cancer Biomarkers Market
Exhibit 68. List of North American Breast Cancer Biomarkers Companies
3.11.1. C.3 European Breast Cancer Biomarkers Market
Exhibit 69. Breast Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 70. Breast Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.1. C.3 (I) German Breast Cancer Biomarkers Market
3.11.1. C.3 (II) United Kingdom Breast Cancer Biomarkers Market
3.11.1. C.3 (III) Italian Breast Cancer Biomarkers Market
3.11.1. C.3 (IV) French Breast Cancer Biomarkers Market
3.11.1. C.3 (V) Spanish Breast Cancer Biomarkers Market
3.11.1. C.3 (VI) Swiss Breast Cancer Biomarkers Market
3.11.1. C.3 (VII) Belgian Breast Cancer Biomarkers Market
3.11.1. C.3 (VIII) Swedish Breast Cancer Biomarkers Market
3.11.1. C.3 (IX) Russian Breast Cancer Biomarkers Market
Exhibit 71. List of European Breast Cancer Biomarkers Companies
3.11.1. C.4 Asia-Pacific Breast Cancer Biomarkers Market
Exhibit 72. Breast Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 73. Breast Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.1. C.4 (I) Japanese Breast Cancer Biomarkers Market
3.11.1. C.4 (II) Chinese Breast Cancer Biomarkers Market
3.11.1. C.4 (III) Indian Breast Cancer Biomarkers Market
3.11.1. C.4 (IV) Australian Breast Cancer Biomarkers Market
3.11.1. C.4 (V) South Korean Breast Cancer Biomarkers Market
Exhibit 74. List of Asia-Pacific Breast Cancer Biomarkers Companies
3.11.1. C.5 Rest of World Breast Cancer Biomarkers Market
Exhibit 75. Breast Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 76. Breast Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.1. C.5 (I) Israeli Breast Cancer Biomarkers Market
3.11.1. C.5 (II) South African Breast Cancer Biomarkers Market
3.11.1. C.5 (III) Brazilian Breast Cancer Biomarkers Market
Exhibit 77. List of Rest of World Breast Cancer Biomarkers Companies
3.11.1. D LUNG CANCER
3.11.1. D.1 Global Lung Cancer Biomarkers Market
Exhibit 78. Lung Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 79. Lung Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.1. D.2 North American Lung Cancer Biomarkers Market
Exhibit 80. Lung Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 81. Lung Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.1. D.2 (I) United States Lung Cancer Biomarkers Market
3.11.1. D.2 (II) Canadian Lung Cancer Biomarkers Market
Exhibit 82. List of North American Lung Cancer Biomarkers Companies
3.11.1. D.3 European Lung Cancer Biomarkers Market
Exhibit 83. Lung Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 84. Lung Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.1. D.3 (I) German Lung Cancer Biomarkers Market
3.11.1. D.3 (II) United Kingdom Lung Cancer Biomarkers Market
3.11.1. D.3 (III) Italian Lung Cancer Biomarkers Market
3.11.1. D.3 (IV) French Lung Cancer Biomarkers Market
3.11.1. D.3 (V) Spanish Lung Cancer Biomarkers Market
3.11.1. D.3 (VI) Swiss Lung Cancer Biomarkers Market
3.11.1. D.3 (VII) Belgian Lung Cancer Biomarkers Market
3.11.1. D.3 (VIII) Swedish Lung Cancer Biomarkers Market
3.11.1. D.3 (IX) Russian Lung Cancer Biomarkers Market
Exhibit 85. List of European Lung Cancer Biomarkers Companies
3.11.1. D.4 Asia-Pacific Lung Cancer Biomarkers Market
Exhibit 86. Lung Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 87. Lung Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.1. D.4 (I) Japanese Lung Cancer Biomarkers Market
3.11.1. D.4 (II) Chinese Lung Cancer Biomarkers Market
3.11.1. D.4 (III) Indian Lung Cancer Biomarkers Market
3.11.1. D.4 (IV) Australian Lung Cancer Biomarkers Market
3.11.1. D.4 (V) South Korean Lung Cancer Biomarkers Market
Exhibit 88. List of Asia-Pacific Lung Cancer Biomarkers Companies
3.11.1. D.5 Rest of World Lung Cancer Biomarkers Market
Exhibit 89. Lung Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 90. Lung Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.1. D.5 (I) Israeli Lung Cancer Biomarkers Market
3.11.1. D.5 (II) South African Lung Cancer Biomarkers Market
3.11.1. D.5 (III) Brazilian Lung Cancer Biomarkers Market
Exhibit 91. List of Rest of World Lung Cancer Biomarkers Companies
3.11.1. E OTHER CANCERS
3.11.1. E.1 Global Other Cancer Biomarkers Market
Exhibit 92. Other Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 93. Other Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.1. E.2 North American Other Cancers Biomarkers Market
Exhibit 94. Other Cancers Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 95. Other Cancers Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 96. List of North American Other Cancers Biomarkers Companies
3.11.1. E.3 European Other Cancers Biomarkers Market
Exhibit 97. Other Cancers Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 98. Other Cancers Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.1. E.4 Asia-Pacific Other Cancers Biomarkers Market
Exhibit 99. Other Cancers Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 100. Other Cancers Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.1. E.5 Rest of World Other Cancers Biomarkers Market
Exhibit 101. Other Cancers Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 102. Other Cancers Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.2 CARDIOLOGY
3.11.2.1 Global Cardiology Biomarkers Market
Exhibit 103. Biomarkers in Cardiology – Global Market Estimations and Predictions (2005-2020) in US$ Million for Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical Representation Included)
Exhibit 104. Biomarkers in Cardiology – Global Market Shares (2010, 2015 & 2020) for Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical Representation Included)
Exhibit 105. Biomarkers in Cardiology – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 106. Biomarkers in Cardiology – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.2 North American Cardiology Biomarkers Market
Exhibit 107. Biomarkers in Cardiology – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 108. Biomarkers in Cardiology – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.2.2 (I) United States Cardiology Biomarkers Market
3.11.2.2 (II)Canadian Cardiology Biomarkers Market
Exhibit 109. List of North American Cardiology Biomarkers Companies
3.11.2.3 European Cardiology Biomarkers Market
Exhibit 110. Biomarkers in Cardiology – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 111. Biomarkers in Cardiology – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.11.2.3 (I) German Cardiology Biomarkers Market
3.11.2.3 (II) United Kingdom Cardiology Biomarkers Market
3.11.2.3 (III) Italian Cardiology Biomarkers Market
3.11.2.3 (IV) French Cardiology Biomarkers Market
3.11.2.3 (V) Spanish Cardiology Biomarkers Market
3.11.2.3 (VI) Swiss Cardiology Biomarkers Market
3.11.2.3 (VII) Belgian Cardiology Biomarkers Market
3.11.2.3 (VIII) Swedish Cardiology Biomarkers Market
3.11.2.3 (IX) Russian Cardiology Biomarkers Market
Exhibit 112. List of European Cardiology Biomarkers Companies
3.11.2.4 Asia-Pacific Cardiology Biomarkers Market
Exhibit 113. Biomarkers in Cardiology – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 114. Biomarkers in Cardiology– Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.2.4 (I) Japanese Cardiology Biomarkers Market
3.11.2.4 (II) Chinese Cardiology Biomarkers Market
3.11.2.4 (III) Indian Cardiology Biomarkers Market
3.11.2.4 (IV) Australian Cardiology Biomarkers Market
3.11.2.4 (V) South Korean Cardiology Biomarkers Market
Exhibit 115. List of Asia-Pacific Cardiology Biomarkers Companies
3.11.2.5 Rest of World Cardiology Biomarkers Market
Exhibit 116. Biomarkers in Cardiology – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 117. Biomarkers in Cardiology – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.2.5 (I) Israeli Cardiology Biomarkers Market
3.11.2.5 (II) South African Cardiology Biomarkers Market
3.11.2.5 (III) Brazilian Cardiology Biomarkers Market
Exhibit 118. List of Rest of World Cardiology Biomarkers Companies
3.11.2.A CORONARY HEART DISEASE
3.11.2.A.1 Global Coronary Heart Disease Biomarkers Market
Exhibit 119. Coronary Heart Disease Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 120. Coronary Heart Disease Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.A.2 North American Coronary Heart Disease Biomarkers Market
Exhibit 121. Coronary Heart Disease Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 122. Coronary Heart Disease Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.2.A.2 (I) United States Coronary Heart Disease Biomarkers Market
3.11.2.A.2 (II) Canadian Coronary Heart Disease Biomarkers Market
Exhibit 123. List of North American Coronary Heart Disease Biomarkers Companies
3.11.2.A.3 European Coronary Heart Disease Biomarkers Market
Exhibit 124. Coronary Heart Disease Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 125. Coronary Heart Disease Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.2.A.3 (I) German Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (II) United Kingdom Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (III) Italian Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (IV) French Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (V) Spanish Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (VI) Swiss Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (VII) Belgian Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (VIII) Swedish Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (IX) Russian Coronary Heart Disease Biomarkers Market
Exhibit 126. List of European Coronary Heart Disease Biomarkers Companies
3.11.2.A.4 Asia-Pacific Coronary Heart Disease Biomarkers Market
Exhibit 127. Coronary Heart Disease Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 128. Coronary Heart Disease Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.2.A.4 (I) Japanese Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (II) Chinese Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (III) Indian Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (IV) Australian Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (V) South Korean Coronary Heart Disease Biomarkers Market
Exhibit 129. List of Asia-Pacific Coronary Heart Disease Biomarkers Companies
3.11.2.A.5 Rest of World Coronary Heart Disease Biomarkers Market
Exhibit 130. Coronary Heart Disease Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 131. Coronary Heart Disease Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.2.A.5 (I) Israeli Coronary Heart Disease Biomarkers Market
3.11.2.A.5 (II) South African Coronary Heart Disease Biomarkers Market
3.11.2.A.5 (III) Brazilian Coronary Heart Disease Biomarkers Market
Exhibit 132. List of Rest of World Coronary Heart Disease Biomarkers Companies
3.11.2.B HEART FAILURE
3.11.2.B.1 Global Heart Failure Biomarkers Market
Exhibit 133. Heart Failure Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 134. Heart Failure Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.B.2 North American Heart Failure Biomarkers Market
Exhibit 135. Heart Failure Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$
Million for USA and Canada (Graphical Representation Included)
Exhibit 136. Heart Failure Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.2.B.2 (I) United States Heart Failure Biomarkers Market
3.11.2.B.2 (II) Canadian Heart Failure Biomarkers Market
Exhibit 137. List of North American Heart Failure Biomarkers Companies
3.11.2.B.3 European Heart Failure Biomarkers Market
Exhibit 138. Heart Failure Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 139. Heart Failure Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.2.B.3 (I) German Heart Failure Biomarkers Market
3.11.2.B.3 (II) United Kingdom Heart Failure Biomarkers Market
3.11.2.B.3 (III) Italian Heart Failure Biomarkers Market
3.11.2.B.3 (IV) French Heart Failure Biomarkers Market
3.11.2.B.3 (V) Spanish Heart Failure Biomarkers Market
3.11.2.B.3 (VI) Swiss Heart Failure Biomarkers Market
3.11.2.B.3 (VII) Belgian Heart Failure Biomarkers Market
3.11.2.B.3 (VIII) Swedish Heart Failure Biomarkers Market
3.11.2.B.3 (IX) Russian Heart Failure Biomarkers Market
Exhibit 140. List of European Heart Failure Biomarkers Companies
3.11.2.B.4 Asia-Pacific Heart Failure Biomarkers Market
Exhibit 141. Heart Failure Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 142. Heart Failure Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.2.B.4 (I) Japanese Heart Failure Biomarkers Market
3.11.2.B.4 (II) Chinese Heart Failure Biomarkers Market
3.11.2.B.4 (III) Indian Heart Failure Biomarkers Market
3.11.2.B.4 (IV) Australian Heart Failure Biomarkers Market
3.11.2.B.4 (V) South Korean Heart Failure Biomarkers Market
Exhibit 143. List of Asia-Pacific Heart Failure Biomarkers Companies
3.11.2.B.5 Rest of World Heart Failure Biomarkers Market
Exhibit 144. Heart Failure Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 145. Heart Failure Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.2.B.5 (I) Israeli Heart Failure Biomarkers Market
3.11.2.B.5 (II) South African Heart Failure Biomarkers Market
3.11.2.B.5 (III) Brazilian Heart Failure Biomarkers Market
Exhibit 146. List of Rest of World Heart Failure Biomarkers Companies
3.11.2.C MYOCARDIAL INFARCTION
3.11.2.C.1 Global Myocardial Infarction Biomarkers Market
Exhibit 147. Myocardial Infarction Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 148. Myocardial Infarction Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.C.2 North American Myocardial Infarction Biomarkers Market
Exhibit 149. Myocardial Infarction Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 150. Myocardial Infarction Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.2.C.2 (I) United States Myocardial Infarction Biomarkers Market
3.11.2.C.2 (II) Canadian Myocardial Infarction Biomarkers Market
Exhibit 151. List of North American Myocardial Infarction Biomarkers Companies
3.11.2.C.3 European Myocardial Infarction Biomarkers Market
Exhibit 152. Myocardial Infarction Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 153. Myocardial Infarction Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.2.C.3 (I) German Myocardial Infarction Biomarkers Market
3.11.2.C.3 (II) United Kingdom Myocardial Infarction Biomarkers Market
3.11.2.C.3 (III) Italian Myocardial Infarction Biomarkers Market
3.11.2.C.3 (IV) French Myocardial Infarction Biomarkers Market
3.11.2.C.3 (V) Spanish Myocardial Infarction Biomarkers Market
3.11.2.C.3 (VI) Swiss Myocardial Infarction Biomarkers Market
3.11.2.C.3 (VII) Belgian Myocardial Infarction Biomarkers Market
3.11.2.C.3 (VIII) Swedish Myocardial Infarction Biomarkers Market
3.11.2.C.3 (IX) Russian Myocardial Infarction Biomarkers Market
Exhibit 154. List of European Myocardial Infarction Biomarkers Companies
3.11.2.C.4 Asia-Pacific Myocardial Infarction Biomarkers Market
Exhibit 155. Myocardial Infarction Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 156. Myocardial Infarction Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.2.C.4 (I) Japanese Myocardial Infarction Biomarkers Market
3.11.2.C.4 (II) Chinese Myocardial Infarction Biomarkers Market
3.11.2.C.4 (III) Indian Myocardial Infarction Biomarkers Market
3.11.2.C.4 (IV) Australian Myocardial Infarction Biomarkers Market
3.11.2.C.4 (V) South Korean Myocardial Infarction Biomarkers Market
Exhibit 157. List of Asia-Pacific Myocardial Infarction Biomarkers Companies
3.11.2.C.5 Rest of World Myocardial Infarction Biomarkers Market
Exhibit 158. Myocardial Infarction Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 159. Myocardial Infarction Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.2.C.5 (I) Israeli Myocardial Infarction Biomarkers Market
3.11.2.C.5 (II) South African Myocardial Infarction Biomarkers Market
3.11.2.C.5 (III) Brazilian Myocardial Infarction Biomarkers Market
Exhibit 160. List of Rest of World Myocardial Infarction Biomarkers Companies
3.11.2.D OTHER CARDIAC BIOMARKERS
3.11.2.D.1 Global Other Cardiac Biomarkers Market
Exhibit 161. Other Cardiac Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 162. Other Cardiac Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.D.2 North American Other Cardiac Biomarkers Market
Exhibit 163. Other Cardiac Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 164. Other Cardiac Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.2.D.3 European Other Cardiac Biomarkers Market
Exhibit 165. Other Cardiac Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 166. Other Cardiac Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.2.D.4 Asia-Pacific Other Cardiac Biomarkers Market
Exhibit 167. Other Cardiac Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 168. Other Cardiac Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.2.D.5 Rest of World Other Cardiac Biomarkers Market
Exhibit 169. Other Cardiac Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 170. Other Cardiac Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.3 NEUROLOGY
3.11.3.1 Global Neurology Biomarkers Market
Exhibit 171. Biomarkers in Neurology- Global Market Estimations and Predictions (2005-2020) in US$ Million or Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation Included)
Exhibit 172. Biomarkers in Neurology- Global Market Shares (2010, 2015 & 2020) for Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation Included)
Exhibit 173. Biomarkers in Neurology – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 174. Biomarkers in Neurology – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.2 North American Neurology Biomarkers Market
Exhibit 175. Biomarkers in Neurology – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 176. Biomarkers in Neurology – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.3.2 (I) United States Neurology Biomarkers Market
3.11.3.2 (II) Canadian Neurology Biomarkers Market
Exhibit 177. List of North American Neurology Biomarkers Companies
3.11.3.3 European Neurology Biomarkers Market
Exhibit 178. Biomarkers in Neurology – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 179. Biomarkers in Neurology – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.11.3.3 (I) German Neurology Biomarkers Market
3.11.3.3 (II) United Kingdom Neurology Biomarkers Market
3.11.3.3 (III) Italian Neurology Biomarkers Market
3.11.3.3 (IV) French Neurology Biomarkers Market
3.11.3.3 (V) Spanish Neurology Biomarkers Market
3.11.3.3 (VI) Swiss Neurology Biomarkers Market
3.11.3.3 (VII) Belgian Neurology Biomarkers Market
3.11.3.3 (VIII) Swedish Neurology Biomarkers Market
3.11.3.3 (IX) Russian Neurology Biomarkers Market
Exhibit 180. List of European Neurology Biomarkers Companies
3.11.3.4 Asia-Pacific Neurology Biomarkers Market
Exhibit 181. Biomarkers in Neurology – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 182. Biomarkers in Neurology – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.3.4 (I) Japanese Neurology Biomarkers Market
3.11.3. 4 (II) Chinese Neurology Biomarkers Market
3.11.3. 4 (III) Indian Neurology Biomarkers Market
3.11.3. 4 (IV) Australian Neurology Biomarkers Market
3.11.3. 4 (V) South Korean Neurology Biomarkers Market
Exhibit 183. List of Asia-Pacific Neurology Biomarkers Companies
3.11.3.5 Rest of World Neurology Biomarkers Market
Exhibit 184. Biomarkers in Neurology – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 185. Biomarkers in Neurology – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.3.5 (I) Israeli Neurology Biomarkers Market
3.11.3. 5 (II) South African Neurology Biomarkers Market
3.11.3. 5 (III) Brazilian Neurology Biomarkers Market
Exhibit 186. List of Rest of World Neurology Biomarkers Companies
3.11.3.A STROKE
3.11.3.A.1 Global Stroke Biomarkers Market
Exhibit 187. Stroke Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 188. Stroke Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.A.2 North American Stroke Biomarkers Market
Exhibit 189. Stroke Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 190. Stroke Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.3.A.2 (I) United States Stroke Biomarkers Market
3.11.3.A.2 (II) Canadian Stroke Biomarkers Market
Exhibit 191. List of North American Stroke Biomarkers Companies
3.11.3.A.3 European Stroke Biomarkers Market
Exhibit 192. Stroke Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 193. Stroke Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.3.A.3 (I) German Stroke Biomarkers Market
3.11.3.A.3 (II) United Kingdom Stroke Biomarkers Market
3.11.3.A.3 (III) Italian Stroke Biomarkers Market
3.11.3.A.3 (IV) French Stroke Biomarkers Market
3.11.3.A.3 (V) Spanish Stroke Biomarkers Market
3.11.3.A.3 (VI) Swiss Stroke Biomarkers Market
3.11.3.A.3 (VII) Belgian Stroke Biomarkers Market
3.11.3.A.3 (VIII) Swedish Stroke Biomarkers Market
3.11.3.A.3 (IX) Russian Stroke Biomarkers Market
Exhibit 194. List of European Stroke Biomarkers Companies
3.11.3.A.4 Asia-Pacific Stroke Biomarkers Market
Exhibit 195. Stroke Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 196. Stroke Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.3.A.4 (I) Japanese Stroke Biomarkers Market
3.11.3.A.4 (II) Chinese Stroke Biomarkers Market
3.11.3.A.4 (III) Indian Stroke Biomarkers Market
3.11.3.A.4 (IV) Australian Stroke Biomarkers Market
3.11.3.A.4 (V) South Korean Stroke Biomarkers Market
Exhibit 197. List of Asia-Pacific Stroke Biomarkers Companies
3.11.3.A.5 Rest of World Stroke Biomarkers Market
Exhibit 198. Stroke Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 199. Stroke Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.3.A.5 (I) Israeli Stroke Biomarkers Market
3.11.3.A.5 (II) South African Stroke Biomarkers Market
3.11.3.A.5 (III) Brazilian Stroke Biomarkers Market
Exhibit 200. List of Rest of World Stroke Biomarkers Companies
3.11.3.B BRAIN TUMOR
3.11.3.B.1 Global Brain Tumor Biomarkers Market
Exhibit 201. Brain Tumor Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 202. Brain Tumor Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.B.2 North American Brain Tumor Biomarkers Market
Exhibit 203. Brain Tumor Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 204. Brain Tumor Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.3.B.2 (I) United States Brain Tumor Biomarkers Market
3.11.3.B.2 (II) Canadian Brain Tumor Biomarkers Market
Exhibit 205. List of North American Brain Tumor Biomarkers Companies
3.11.3.B.3 European Brain Tumor Biomarkers Market
Exhibit 206. Brain Tumor Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 207. Brain Tumor Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.3.B.3 (I) German Brain Tumor Biomarkers Market
3.11.3.B.3 (II) United Kingdom Brain Tumor Biomarkers Market
3.11.3.B.3 (III) Italian Brain Tumor Biomarkers Market
3.11.3.B.3 (IV) French Brain Tumor Biomarkers Market
3.11.3.B.3 (V) Spanish Brain Tumor Biomarkers Market
3.11.3.B.3 (VI) Swiss Brain Tumor Biomarkers Market
3.11.3.B.3 (VII) Belgian Brain Tumor Biomarkers Market
3.11.3.B.3 (VIII) Swedish Brain Tumor Biomarkers Market
3.11.3.B.3 (IX) Russian Brain Tumor Biomarkers Market
Exhibit 208. List of European Brain Tumor Biomarkers Companies
3.11.3.B.4 Asia-Pacific Brain Tumor Biomarkers Market
Exhibit 209. Brain Tumor Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 210. Brain Tumor Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.11.3.B.4 (I) Japanese Brain Tumor Biomarkers Market
3.11.3.B.4 (II) Chinese Brain Tumor Biomarkers Market
3.11.3.B.4 (III) Indian Brain Tumor Biomarkers Market
3.11.3.B.4 (IV) Australian Brain Tumor Biomarkers Market
3.11.3.B.4 (V) South Korean Brain Tumor Biomarkers Market
Exhibit 211. List of Asia-Pacific Brain Tumor Biomarkers Companies
3.11.3.B.5 Rest of World Brain Tumor Biomarkers Market
Exhibit 212. Brain Tumor Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 213. Brain Tumor Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.3.B.5 (I) Israeli Brain Tumor Biomarkers Market
3.11.3.B.5 (II) South African Brain Tumor Biomarkers Market
3.11.3.B.5 (III) Brazilian Brain Tumor Biomarkers Market
Exhibit 214. List of Rest of World Brain Tumor Biomarkers Companies
3.11.3.C NEURODEGENERATIVE DISEASES
3.11.3.C.1 Global Neurodegenerative Diseases Biomarkers Market
Exhibit 215. Neurodegenerative Diseases Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 216. Neurodegenerative Diseases Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.C.2 North American Neurodegenerative Diseases Biomarkers Market
Exhibit 217. Neurodegenerative Diseases Biomarkers– North American Market Estimations and Predictions (2005-
2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 218. Neurodegenerati

Exhibit 1. Segmentation of Global Biomarkers Market by Therapeutic Area and Identification Technology
Exhibit 2. Segmentation by Therapeutic Area for Oncology, Cardiology, Neurology, and Infectious Diseases
Exhibit 3. Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Billion (Graphical Representation Included)
Exhibit 4. List of Global Major Biomarkers Companies
Exhibit 5. Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 6. Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 7. Biomarkers – North American Market Estimations & Predictions (2005 -2020) in US$ Million for United States and Canada (Graphical Representation Included)
Exhibit 8. Biomarkers – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
Exhibit 9. List of North American Biomarkers Companies
Exhibit 10. Biomarkers – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 11. Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 12. List of European Biomarkers Companies
Exhibit 13. Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 14. Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 15. List of Asia-Pacific Biomarkers Companies
Exhibit 16. Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 17. Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 18. List of Rest of World Biomarkers Companies
Exhibit 19. Biomarkers by Therapeutic Area – Global Market Estimations and Predictions (2005-2020) in US$ Million for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included)
Exhibit 20. Biomarkers – Global Market Shares (2010, 2015 & 2020) for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included)
Exhibit 21. Biomarkers in Oncology – Global Market Estimations and Predictions (2005-2020) in US$ Million for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included)
Exhibit 22. Biomarkers in Oncology – Global Market Shares (2010, 2015 & 2020) for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included)
Exhibit 23. Biomarkers in Oncology – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 24. Biomarkers in Oncology – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 25. Biomarkers in Oncology – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 26. Biomarkers in Oncology – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 27. List of North American Oncology Biomarkers Companies
Exhibit 28. Biomarkers in Oncology – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 29. Biomarkers in Oncology – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 30. List of European Oncology Biomarkers Companies
Exhibit 31. Biomarkers in Oncology – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 32. Biomarkers in Oncology– Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 33. List of Asia-Pacific Oncology Biomarkers Companies
Exhibit 34. Biomarkers in Oncology – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 35. Biomarkers in Oncology – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 36. List of Rest of World Oncology Biomarkers Companies
Exhibit 37. Prostate Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 38. Prostate Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 39. Prostate Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 40. Prostate Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 41. List of North American Prostate Cancer Biomarkers Companies
Exhibit 42. Prostate Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 43. Prostate Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 44. List of European Prostate Cancer Biomarkers Companies
Exhibit 45. Prostate Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 46. Prostate Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 47. List of Asia-Pacific Prostate Cancer Biomarkers Companies
Exhibit 48. Prostate Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 49. Prostate Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 50. Ovarian Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 51. Ovarian Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 52. Ovarian Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 53. Ovarian Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada
Exhibit 54. List of North American Ovarian Cancer Biomarkers Companies
Exhibit 55. Ovarian Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 56. Ovarian Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 57. List of European Ovarian Cancer Biomarkers Companies
Exhibit 58. Ovarian Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 59. Ovarian Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 60. List of Asia-Pacific Ovarian Cancer Biomarkers Companies
Exhibit 61. Ovarian Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 62. Ovarian Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil
Exhibit 63. List of Rest of World Ovarian Cancer Biomarkers Companies
Exhibit 64. Breast Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 65. Breast Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 66. Breast Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 67. Breast Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 68. List of North American Breast Cancer Biomarkers Companies
Exhibit 69. Breast Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 70. Breast Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 71. List of European Breast Cancer Biomarkers Companies
Exhibit 72. Breast Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 73. Breast Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 74. List of Asia-Pacific Breast Cancer Biomarkers Companies
Exhibit 75. Breast Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 76. Breast Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 77. List of Rest of World Breast Cancer Biomarkers Companies
Exhibit 78. Lung Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 79. Lung Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 80. Lung Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 81. Lung Cancer Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 82. List of North American Lung Cancer Biomarkers Companies
Exhibit 83. Lung Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 84. Lung Cancer Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 85. List of European Lung Cancer Biomarkers Companies
Exhibit 86. Lung Cancer Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 87. Lung Cancer Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 88. List of Asia-Pacific Lung Cancer Biomarkers Companies
Exhibit 89. Lung Cancer Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 90. Lung Cancer Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 91. List of Rest of World Lung Cancer Biomarkers Companies
Exhibit 92. Other Cancer Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 93. Other Cancer Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 94. Other Cancers Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 95. Other Cancers Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 96. List of North American Other Cancers Biomarkers Companies
Exhibit 97. Other Cancers Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 98. Other Cancers Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 99. Other Cancers Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 100. Other Cancers Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 101. Other Cancers Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 102. Other Cancers Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 103. Biomarkers in Cardiology – Global Market Estimations and Predictions (2005-2020) in US$ Million for Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical Representation Included)
Exhibit 104. Biomarkers in Cardiology – Global Market Shares (2010, 2015 & 2020) for Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical Representation Included)
Exhibit 105. Biomarkers in Cardiology – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 106. Biomarkers in Cardiology – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 107. Biomarkers in Cardiology – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 108. Biomarkers in Cardiology – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 109. List of North American Cardiology Biomarkers Companies
Exhibit 110. Biomarkers in Cardiology – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 111. Biomarkers in Cardiology – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 112. List of European Cardiology Biomarkers Companies
Exhibit 113. Biomarkers in Cardiology – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 114. Biomarkers in Cardiology– Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 115. List of Asia-Pacific Cardiology Biomarkers Companies
Exhibit 116. Biomarkers in Cardiology – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 117. Biomarkers in Cardiology – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 118. List of Rest of World Cardiology Biomarkers Companies
Exhibit 119. Coronary Heart Disease Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 120. Coronary Heart Disease Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 121. Coronary Heart Disease Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 122. Coronary Heart Disease Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 123. List of North American Coronary Heart Disease Biomarkers Companies
Exhibit 124. Coronary Heart Disease Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 125. Coronary Heart Disease Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 126. List of European Coronary Heart Disease Biomarkers Companies
Exhibit 127. Coronary Heart Disease Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 128. Coronary Heart Disease Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 129. List of Asia-Pacific Coronary Heart Disease Biomarkers Companies
Exhibit 130. Coronary Heart Disease Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 131. Coronary Heart Disease Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 132. List of Rest of World Coronary Heart Disease Biomarkers Companies
Exhibit 133. Heart Failure Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 134. Heart Failure Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 135. Heart Failure Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$
Exhibit 136. Heart Failure Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 137. List of North American Heart Failure Biomarkers Companies
Exhibit 138. Heart Failure Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 139. Heart Failure Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 140. List of European Heart Failure Biomarkers Companies
Exhibit 141. Heart Failure Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 142. Heart Failure Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 143. List of Asia-Pacific Heart Failure Biomarkers Companies
Exhibit 144. Heart Failure Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 145. Heart Failure Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 146. List of Rest of World Heart Failure Biomarkers Companies
Exhibit 147. Myocardial Infarction Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 148. Myocardial Infarction Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 149. Myocardial Infarction Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 150. Myocardial Infarction Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 151. List of North American Myocardial Infarction Biomarkers Companies
Exhibit 152. Myocardial Infarction Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 153. Myocardial Infarction Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 154. List of European Myocardial Infarction Biomarkers Companies
Exhibit 155. Myocardial Infarction Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 156. Myocardial Infarction Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 157. List of Asia-Pacific Myocardial Infarction Biomarkers Companies
Exhibit 158. Myocardial Infarction Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 159. Myocardial Infarction Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 160. List of Rest of World Myocardial Infarction Biomarkers Companies
Exhibit 161. Other Cardiac Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 162. Other Cardiac Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 163. Other Cardiac Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 164. Other Cardiac Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 165. Other Cardiac Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 166. Other Cardiac Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 167. Other Cardiac Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 168. Other Cardiac Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 169. Other Cardiac Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 170. Other Cardiac Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 171. Biomarkers in Neurology- Global Market Estimations and Predictions (2005-2020) in US$ Million or Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation Included)
Exhibit 172. Biomarkers in Neurology- Global Market Shares (2010, 2015 & 2020) for Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation Included)
Exhibit 173. Biomarkers in Neurology – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 174. Biomarkers in Neurology – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 175. Biomarkers in Neurology – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 176. Biomarkers in Neurology – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 177. List of North American Neurology Biomarkers Companies
Exhibit 178. Biomarkers in Neurology – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 179. Biomarkers in Neurology – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 180. List of European Neurology Biomarkers Companies
Exhibit 181. Biomarkers in Neurology – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 182. Biomarkers in Neurology – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 183. List of Asia-Pacific Neurology Biomarkers Companies
Exhibit 184. Biomarkers in Neurology – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 185. Biomarkers in Neurology – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 186. List of Rest of World Neurology Biomarkers Companies
Exhibit 187. Stroke Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 188. Stroke Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 189. Stroke Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 190. Stroke Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 191. List of North American Stroke Biomarkers Companies
Exhibit 192. Stroke Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 193. Stroke Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 194. List of European Stroke Biomarkers Companies
Exhibit 195. Stroke Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 196. Stroke Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 197. List of Asia-Pacific Stroke Biomarkers Companies
Exhibit 198. Stroke Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 199. Stroke Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 200. List of Rest of World Stroke Biomarkers Companies
Exhibit 201. Brain Tumor Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 202. Brain Tumor Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 203. Brain Tumor Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 204. Brain Tumor Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 205. List of North American Brain Tumor Biomarkers Companies
Exhibit 206. Brain Tumor Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 207. Brain Tumor Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 208. List of European Brain Tumor Biomarkers Companies
Exhibit 209. Brain Tumor Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 210. Brain Tumor Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 211. List of Asia-Pacific Brain Tumor Biomarkers Companies
Exhibit 212. Brain Tumor Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 213. Brain Tumor Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 214. List of Rest of World Brain Tumor Biomarkers Companies
Exhibit 215. Neurodegenerative Diseases Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 216. Neurodegenerative Diseases Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 217. Neurodegenerative Diseases Biomarkers– North American Market Estimations and Predictions (2005-
Exhibit 218. Neurodegenerative Diseases Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 219. List of North American Neurodegenerative Diseases Biomarkers Companies
Exhibit 220. Neurodegenerative Diseases Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 221. Neurodegenerative Diseases Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 222. List of European Neurodegenerative Diseases Biomarkers Companies
Exhibit 223. Neurodegenerative Diseases Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 224. Neurodegenerative Diseases Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 225. List of Asia-Pacific Neurodegenerative Diseases Biomarkers Companies
Exhibit 226. Neurodegenerative Diseases Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 227. Neurodegenerative Diseases Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 228. List of Rest of World Neurodegenerative Diseases Biomarkers Companies
Exhibit 229. Other Neurological Disorder Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 230. Other Neurological Disorder Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 231. Other Neurological Disorder Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 232. Other Neurological Disorder Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 233. Other Neurological Disorder Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 234. Other Neurological Disorder Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 235. Other Neurological Disorder Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 236. Other Neurological Disorder Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 237. Other Neurological Disorder Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 238. Other Neurological Disorder Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 239. Biomarkers for Infectious Diseases- Global Market Estimations and Predictions (2005-2020) in US$ Million for GIT, Respiratory Tract infections and Other (Graphical Representation Included)
Exhibit 240. Biomarkers for Infectious Diseases- Global Market Shares (2010, 2015 & 2020) for GIT, Respiratory Tract infections and Other (Graphical Representation Included)
Exhibit 241. Biomarkers for Infectious Diseases – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 242. Biomarkers for Infectious Diseases – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 243. Biomarkers for Infectious Diseases – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 244. Biomarkers for Infectious Diseases – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 245. List of North American Infectious Diseases’ Biomarkers Companies
Exhibit 246. Biomarkers for Infectious Diseases – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 247. Biomarkers for Infectious Diseases – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 248. List of European Infectious Diseases’ Biomarkers Companies
Exhibit 249. Biomarkers for Infectious Diseases – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 250. Biomarkers for Infectious Diseases – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 251. List of Asia-Pacific Infectious Diseases’ Biomarkers Companies
Exhibit 252. Biomarkers for Infectious Diseases – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 253. Biomarkers for Infectious Diseases – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 254. List of Rest of World Infectious Diseases’ Biomarkers Companies
Exhibit 255. Gastrointestinal Tract Infection (GIT) Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 256. Gastrointestinal Tract Infection (GIT) Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 257. Gastrointestinal Tract Infection (GIT) Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 258. Gastrointestinal Tract Infection (GIT) Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 259. List of North American Gastrointestinal Tract Infection (GIT) Biomarkers Companies
Exhibit 260. Gastrointestinal Tract Infection (GIT) Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 261. Gastrointestinal Tract Infection (GIT) Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 262. List of European Gastrointestinal Tract Infection (GIT) Biomarkers Companies
Exhibit 263. Gastrointestinal Tract Infection (GIT) Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 264. Gastrointestinal Tract Infection (GIT) Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 265. List of Asia-Pacific Gastrointestinal Tract Infection (GIT) Biomarkers Companies
Exhibit 266. Gastrointestinal Tract Infection (GIT) Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 267. Gastrointestinal Tract Infection (GIT) Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 268. List of Rest of World Gastrointestinal Tract Infection (GIT) Biomarkers Companies
Exhibit 269. Respiratory Tract Infection Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 270. Respiratory Tract Infection Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 271. Respiratory Tract Infection Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 272. Respiratory Tract Infection Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 273. List of North American Respiratory Tract Infection Biomarkers Companies
Exhibit 274. Respiratory Tract Infection Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 275. Respiratory Tract Infection Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 276. List of European Respiratory Tract Infection Biomarkers Companies
Exhibit 277. Respiratory Tract Infection Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 278. Respiratory Tract Infection Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 279. List of Asia-Pacific Respiratory Tract Infection Biomarkers Companies
Exhibit 280. Respiratory Tract Infection Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 281. Gastrointestinal Tract Infection (GIT) Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 282. List of Rest of World Respiratory Tract Infection Biomarkers Companies
Exhibit 283. Other Infectious Disease Biomarkers – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 284. Other Infectious Disease Biomarkers – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 285. Other Infectious Disease Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 286. Other Infectious Disease Biomarkers – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 287. Other Infectious Disease Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 288. Other Infectious Disease Biomarkers – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 289. Other Infectious Disease Biomarkers – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 290. Other Infectious Disease Biomarkers – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 291. Other Infectious Disease Biomarkers – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 292. Other Infectious Disease Biomarkers – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 293. Biomarkers for Genetic Disorders – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 294. Biomarkers for Genetic Disorders – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 295. Biomarkers for Genetic Disorders – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 296. Biomarkers for Genetic Disorders – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 297. List of North American Genetic Disorders’ Biomarkers Companies
Exhibit 298. Biomarkers for Genetic Disorders – European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 299. Biomarkers for Genetic Disorders – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 300. List of European Genetic Disorders’ Biomarkers Companies
Exhibit 301. Biomarkers for Genetic Disorders – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 302. Biomarkers for Genetic Disorders – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 303. List of Asia-Pacific Genetic Disorders’ Biomarkers Companies
Exhibit 304. Biomarkers for Genetic Disorders – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 305. Biomarkers for Genetic Disorders – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 306. List of Rest of World Genetic Disorders’ Biomarkers Companies
Exhibit 307. Biomarkers for Other Therapeutic Areas – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 308. Biomarkers for Other Therapeutic Areas – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 309. Biomarkers for Other Therapeutic Areas – North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 310. Biomarkers for Other Therapeutic Areas – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 311. Biomarkers for Other Therapeutic Areas – European Market Estimations and Predictions (2005-2020)
Exhibit 312. Biomarkers for Other Therapeutic Areas – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 313. Biomarkers for Other Therapeutic Areas – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 314. Biomarkers for Other Therapeutic Areas – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 315. Biomarkers for Other Therapeutic Areas – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million in US$ Million (Graphical Representation Included)
Exhibit 316. Biomarkers for Other Therapeutic Areas – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 317. Biomarkers by Identification Technology – Global Market Estimations and Predictions (2005-2020) in US$ Million for Imaging, Genomics, Proteomics, Metabolomics, Gene Expression & Other (Graphical Representation Included)
Exhibit 318. Biomarkers – Global Market Shares (2010, 2015 & 2020) for Imaging, Genomics, Proteomics, Metabolomics, Gene Expression & Other (Graphical Representation Included)
Exhibit 319. Imaging Technologies for Biomarker Identification – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 320. Imaging Technologies for Biomarker Identification – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 321. Imaging Technologies for Biomarker Identification– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 322. Imaging Technologies for Biomarker Identification – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 323. List of North American Biomarkers Imaging Technologies Companies
Exhibit 324. Imaging Technologies for Biomarker Identification– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe
Exhibit 325. Imaging Technologies for Biomarker Identification – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 326. List of European Biomarkers Imaging Technologies Companies
Exhibit 327. Imaging Technologies for Biomarker Identification – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 328. Imaging Technologies for Biomarker Identification – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 329. List of Asia-Pacific Biomarkers Imaging Technologies Companies
Exhibit 330. Imaging Technologies for Biomarker Identification – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 331. Imaging Technologies for Biomarker Identification – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 332. List of Rest of World Biomarkers Imaging Technologies Companies
Exhibit 333. Genomic Technologies for Biomarker Identification – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 334. Genomic Technologies for Biomarker Identification – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 335. Genomic Technologies for Biomarker Identification– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 336. Genomic Technologies for Biomarker Identification – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 337. List of North American Biomarkers Genomic Technologies Companies
Exhibit 338. Genomic Technologies for Biomarker Identification– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 339. Genomic Technologies for Biomarker Identification – European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 340. List of European Biomarkers Genomic Technologies Companies
Exhibit 341. Genomic Technologies for Biomarker Identification – Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation
Exhibit 342. Genomic Technologies for Biomarker Identification – Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 343. List of Asia-Pacific Biomarkers Genomic Technologies Companies
Exhibit 344. Genomic Technologies for Biomarker Identification – Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 345. Genomic Technologies for Biomarker Identification – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 346. List of Rest of World Biomarkers Genomic Technologies Companies
Exhibit 347. Proteomic Technologies for Biomarker Identification – Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 348. Proteomic Technologies for Biomarker Identification – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 349. Proteomic Technologies for Biomarker Identification– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 350. Proteomic Technologies for Biomarker Identification – North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
Exhibit 351. List of North American Biomarkers Proteomic Technologies Companies
Exhibit 352. Proteomic Technologies for Biomarker Identification– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 353. Proteomic Technologies for B

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +